Patent details

EP2521783 Title: OLIGONUCLEOTIDE COMPOUNDS COMPRISING NON-NUCLEOTIDE OVERHANGS

Basic Information

Publication number:
EP2521783
PCT Application Number:
US2011020298
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP117017061
PCT Publication Number:
WO2011085056
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
OLIGONUCLEOTIDE COMPOUNDS COMPRISING NON-NUCLEOTIDE OVERHANGS
French Title of Invention:
COMPOSÉS OLIGONUCLÉOTIDIQUES COMPRENANT DES DÉBORDS NON NUCLÉOTIDIQUES
German Title of Invention:
OLIGONUKLEOTIDVERBINDUNGEN MIT NICHT-NUKLEODTID-ÜBERHÄNGEN
SPC Number:

Dates

Filing date:
06/01/2011
Grant date:
09/08/2017
EP Publication Date:
14/11/2012
PCT Publication Date:
14/07/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
09/08/2017
EP B1 Publication Date:
09/08/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
06/01/2018
Expiration date:
06/01/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/08/2017
 
 

Name:
Quark Pharmaceuticals, Inc.
Address:
6501 Dumbarton Circle, Fremont, California 94555, United States (US)

Inventor

1

Name:
FEINSTEIN, Elena
Address:
Israel (IL)

2

Name:
AVKIN-NACHUM, Sharon
Address:
Israel (IL)

Priority

1

Priority Number:
292878 P
Priority Date:
07/01/2010
Priority Country:
United States (US)

2

Priority Number:
PCT/US2010/049047
Priority Date:
16/09/2010
Priority Country:
World Intellectual Property Office (WIPO) (WO)

Classification

IPC classification:
C12N 15/113;

Publication

European Patent Bulletin

Issue number:
201732
Publication date:
09/08/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
31/05/2018 Outgoing Correspondence 1